Dr. Ralph Moss of cancerdecisions.com has released a report on Dr. Coley’s toxins.  As most of the folks that follow me know Dr. Moss is a hero to those fighting for a patients right to choose treatment instead of death.  I applaud Dr. Moss for his work and encourage everyone to read his books and purchase the specific reports you need to guide you in making wise decisions with a worldwide view.

ANNOUNCING REPORT ON COLEY’S TOXINS

This week I am proud to announce publication of my latest online report,
Coley’s Toxins: The Sum of Our Hope. Coley’s toxins were-and are-among
the most promising cancer treatments ever devised. They have existed in
one form of another for over 100 years. But since the 1960s they have
been effectively banned in the United States, although they are still
available in several other countries (including Mexico and Germany).
What exactly are Coley’s toxins (also called mixed bacterial vaccine)?
They are a powerful stimulator of the immune system made up of the
killed byproducts (or “toxins”) of two potent bacteria. The first of
these is Streptococcus pyogenes, which causes the skin disease
erysipelas among other illnesses. The other is Serratia marcescens
(formerly known as Bacillus prodigiosus), which potentiates the action
of other bacteria and has independent anticancer activity.

After observing that the skin disease erysipelas sometimes triggers the
“spontaneous” regression of tumors, William B. Coley, MD (chief of the
bone cancer service at what is now Memorial Sloan-Kettering Cancer
Center in New York) began to use a killed mixture of bacteria in the
treatment of cancer. For many years, Coley’s toxins were manufactured by
the Parke-Davis Co. and were accepted by the American Medical
Association (AMA). After Coley’s death in 1936, his son, Bradley,
inherited his practice and continued to use the toxins until the early
1960s. But after passage of strict new amendments to the Food and Drug
Act, the FDA refused to “grandfather” Coley’s treatment (i.e., accepted
them as a long-established part of medicine, as they did, for instance,
with aspirin) but banned it as a “new drug.” This “new drug” was at that
time almost 75 years old.

This brand new 100-page report, with its many illustrations and 285
footnotes, contains the full story of one of the greatest unsung heroes
of modern medicine. William B. Coley devised what was arguably the first
effective non-surgical treatment for cancer and used it on over 1,000
patients between 1892 and 1936. The outcomes in these cases were
meticulously documented by his daughter, Helen Coley Nauts, in a series
of 20 or so disease-specific monographs.

The Coley story is a human drama of the greatest importance in
understanding the struggle between the conventional and alternative
trends in cancer research. It is also a collective tragedy, since this
promising treatment was effectively destroyed by a branch of the US
government, the FDA, and is not widely known, researched or used today.

I first became aware of Coley’s toxins in 1974 when I interviewed
Kanematsu Sugiura, DSc, who had been Coley’s colleague at Memorial
Hospital in the 1920s. In the following year I interviewed Mrs. Nauts at
her apartment on New York’s Park Avenue. I wrote a chapter on William B.
Coley in my first book, The Cancer Industry (1980).
<http://www.amazon.com/gp/product/1881025098?ie=UTF8&tag=cancerdecisio-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=1881025098>
But since then a great deal of valuable new information has emerged
about Coley’s heroic struggle to establish this unusual treatment. In
preparation for this new report I interviewed some of the world’s
experts on Coley’s toxins and elicited their thoughts on the safety and
effectiveness of this treatment. I believe that the basis now exists for
reevaluating Coley’s results and reviving what was best in his methods.

It is a great pleasure for me to publish a full account of Coley’s
toxins, which will undoubtedly come as a revelation to readers who
suspect that there are more promising treatments available than the
limited options that are usually offered by standard oncology.

ADVANCE COMMENTS ON RALPH MOSS’ COLEY’S TOXINS: THE SUM OF OUR HOPE

“I found Ralph Moss’s report on the work of Dr. William B. Coley
fascinating. I agree that Coley’s procedure should be re-investigated,
particularly in well controlled clinical trials, so that it can be
appraised properly once and for all.”

-Jacques Miller, MD, PhD, FRS, discoverer of the immunological function
of the thymus and of the two major subsets of lymphocytes (T cells and B
cells)

“This is a must-read for cancer patients, physicians and cancer
researchers. As usual, Ralph Moss has done an excellent job explaining a
complicated and tragic history that has for too long been ignored by
those responsible for public health. In the treatment of cancer, there
is nothing on the medical horizon more important than the work of
Coley.”

-Don MacAdam, chief executive officer, MBVax Bioscience, Inc.

“In Coley’s Toxins, Ralph Moss completes the recuperative historical
project begun in his classic book, The Cancer Industry. For the first
time we have a comprehensive history of over a century of research on
the bacterial vaccine therapy…. If enough people join with Ralph Moss
in demanding that the undone science gets done, we may well find that a
safe, affordable, and efficacious treatment for cancer has been
available for over a hundred years.”

-David J. Hess, PhD, Professor of Science and Technology Studies,
Rensselaer Polytechnic Institute

“Despite my many years of research on Dr William B. Coley, Ralph Moss
has revealed many new insights into who Coley was, the challenges he
faced in establishing immunology as a new treatment for cancer, and what
his work will mean in the future for patients with cancer.”

-Stephen A. Hoption Cann, PhD, University of British Columbia

Coley’s Toxins: The Sum of Our Hope :
http://www.cancerdecisions.com/mrstore/index.php?main_page=product_info&cPath=84&products_id=627